CVS Health Corporation's margins and the medical benefit ratio are showing early signs of recovery. Read why I rate CVS stock ...

Good for what ails a stock portfolio. CVS reached nine-figure territory with that quarter's revenue, which came in slightly ...

CVS Health (CVS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Pharmacy retailer CVS Health (NYSE: CVS) is coming off an impressive bounce-back year in 2025 when its share price soared by 77%. A year earlier, it looked as if it was in an endless tailspin, falling ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Shares of CVS Health were headed for their best day in more than five months as all of its business segments saw double-digit percentage revenue growth Shares of CVS Health Corp. shot higher in early ...

Shares of CVS Health (NYSE: CVS) have lagged the S&P 500 in total return this year, reinforcing a familiar narrative about the healthcare company: a mature, slow-growing grinder. However, that view ...

CVS Health (NYSE:CVS) is scheduled to announce its earnings on Thursday, July 31, 2025. For event-driven traders, analyzing the stock's historical behavior around earnings releases can provide ...

CVS Health Corporation (NYSE:CVS) continues to be favored by Jim Cramer in the pharmaceutical retailer space. Its shares are ...

The stock trades at just 11 times earnings estimates for the next 12 months, much cheaper than rivals UnitedHealth and Humana ...

Earlier this year, CVS Health shares fell after reports that Medicare payment rates would only increase by 0.09% next year. However, with Medicare's final ruling selecting a much higher 2.5% ...